Lentiviral vectors derived from sivagm, methods for their preparation and their use for gene transfer into mammalian cells
CA 2298892 A1 · Owner: Cichutek, Klaus · Inventors: Cichutek, Klaus
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The preparation and use of novel lentiviral SIVagm-derived vectors for gene transfer and in, particular a method of preparation of the lentiviral vectors containing capsid particles of the, simian immunodeficiency virus SIVagm and envelope proteins of SIVagm and other retroviruses such as the human immunodeficiency viruses (HIV) other simian, immunodeficiency viruses (SIV) other retroviruses such as the murine leukemia virus (MLV), or the "gibbon ape leukemia virus" (GaLV) or the porcine endogenous or exogenous, retrovirus (PERV), the "vesicular stomatitis virus" (VSV-G) are described. The vectors and, corresponding packaging cells may be employed for packaging and transfer of genes …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 3, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 3, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 3, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.